Cryonic Medical

27/05/2026

25/05/2026

19/05/2026

🇧🇷 Exciting milestone for Cryonic Medical!

Following the recent ANVISA homologation of our CryoScreen medical device, we are proud to announce that CryoScreen will be presented for the very first time to the Brazilian market during Hospitalar 2026, one of the largest healthcare and medical technology events in Latin America.

📍 São Paulo, Brazil
📅 May 19–22, 2026

Together with our Brazilian partner Dorja Equipamentos Médicos, we will showcase how CryoScreen is bringing a new generation of precise, non-invasive localized cryotherapy solutions to healthcare professionals and patients.

This important step marks the beginning of Cryonic Medical’s expansion into the Brazilian healthcare market and reinforces our commitment to delivering innovative medical technologies internationally.

A special thank you to all partners, distributors, regulatory teams and healthcare professionals who contributed to making this milestone possible.

We look forward to meeting healthcare professionals, distributors and partners at Hospitalar 2026.

18/05/2026

22/04/2026

08/04/2026

🚀 Major milestone for Cryonic Medical!

We are proud to announce that CryoScreen has officially obtained Anvisa certification, enabling us to enter the Brazilian market.

This achievement marks a significant step in our international expansion and reflects the robustness, safety, and clinical value of our technology.

Brazil represents a key market with strong demand for innovative, non-invasive solutions in pain management and rehabilitation. We are excited to bring CryoScreen to healthcare professionals and patients across the country.

A special thank you to all teams and partners involved in making this possible—your dedication made the difference.

We are also looking forward to building a strong and successful journey with our local partner https://www.instagram.com/dorjaindustria/ https://www.facebook.com/dorjamedicate.

🌍 The journey continues.

01/04/2026

Huge congratulations to the team — and especially to Filomena Falcone — for the outstanding presentation of CryoScreen at the Medicol 2026 congress in Lausanne!
It’s fantastic to see CryoScreen showcased so effectively in close interaction with both hand and shoulder surgery specialists. Demonstrating its anti-inflammatory and anesthetic capabilities in such demanding clinical environments truly reinforces its relevance and impact.
Thank you for your energy, commitment, and for bringing CryoScreen closer to top-tier medical experts!

31/03/2026

🔥 Great news from KIMES 2026!

CryoScreen had a fantastic show in Seoul 🇰🇷

Over 4 days:
👉 Hundreds of visitors engaged with our solution
👉 Strong interest from physiotherapists and medical professionals
👉 High-quality discussions with international buyers

The feedback was clear: the market is ready, and the demand is real.

This is a strong validation of CryoScreen’s positioning and a great step forward in our international development 🚀

Big thanks to our partners and everyone who visited us!

27/02/2026

The Kongresse Osteologie + Alterstraumatologie in Frankfurt am Main has now come to a close, and we are pleased to share a few highlights from three days of insightful discussions and live demonstrations.

Together with our German distributor, , we had the opportunity to present CryoScreen to a highly engaged audience of osteology and geriatric traumatology specialists.

Throughout the congress:
• Numerous live demonstrations were conducted at the booth
• In-depth conversations focused on clinical applications and workflow integration
• Strong interest was expressed in rapid, non-invasive screening solutions supporting early risk detection and improved patient management

The quality of the exchanges and the relevance of the feedback confirm the growing need for innovative tools addressing bone health challenges in ageing populations.

A sincere thank you to all healthcare professionals and partners who visited the booth and shared their insights.

We look forward to continuing these discussions and turning promising conversations into concrete collaborations.

26/02/2026

26/02/2026